Chris Markoch, Associate Editor & Contributing Author at MarketBeat Articles by Chris Markoch - Page 36March 14, 2024 4:05 AM ETAirship AI Holdings Is a Stock You Need to Know AboutReviewed by Chris MarkochNYSE:PLTRNASDAQ:AISPRead Airship AI Holdings Is a Stock You Need to Know AboutMarch 13, 2024 4:20 AM ETIs it Time to Buy These 3 Underperforming Magnificent Seven Members?Reviewed by Chris MarkochNASDAQ:TSLANASDAQ:NVDANASDAQ:AAPLRead Is it Time to Buy These 3 Underperforming Magnificent Seven Members?March 13, 2024 4:10 AM ETSea Limited: The One-Stop Digital Consumer Platform of AsiaReviewed by Chris MarkochNYSE:SENASDAQ:AMZNNASDAQ:ATVIRead Sea Limited: The One-Stop Digital Consumer Platform of AsiaMarch 13, 2024 4:05 AM ETNetApp Still a Value Play in the Data Management Segment Reviewed by Chris MarkochNASDAQ:NTAPNYSE:PSTGNASDAQ:AMZNRead NetApp Still a Value Play in the Data Management Segment March 12, 2024 7:45 AM ETGameStop Stock Is Giving Investors a Familiar Feeling, But Why?Chris MarkochNYSE:GMERead GameStop Stock Is Giving Investors a Familiar Feeling, But Why?March 12, 2024 4:10 AM ETIs Hewlett Packard Enterprises Still a Cheap AI Server Play?Reviewed by Chris MarkochNYSE:HPENASDAQ:SMCINYSE:DELLRead Is Hewlett Packard Enterprises Still a Cheap AI Server Play?March 12, 2024 4:05 AM ETSamsara's Surging Momentum Following Earnings BeatReviewed by Chris MarkochNYSE:IOTRead Samsara's Surging Momentum Following Earnings BeatMarch 11, 2024 4:20 AM ETHere’s The One Pet Stock That’s Not in the DoghouseReviewed by Chris MarkochNASDAQ:FRPTNYSE:CHWYNASDAQ:WOOFRead Here’s The One Pet Stock That’s Not in the DoghouseMarch 11, 2024 4:15 AM ETMedtronic is a Dividend Aristocrat That Keeps Gaining Reviewed by Chris MarkochNYSE:MDTNYSE:ABTRead Medtronic is a Dividend Aristocrat That Keeps Gaining March 11, 2024 4:10 AM ETUlta Beauty Is the Value Play You Must Hold This DecadeReviewed by Chris MarkochNYSE:DKSNYSE:UBSNYSE:JPMRead Ulta Beauty Is the Value Play You Must Hold This DecadeMarch 11, 2024 4:05 AM ET3 Metal Stocks with Double-Digit UpsideReviewed by Chris MarkochNASDAQ:CMENYSE:AIGNYSE:GSRead 3 Metal Stocks with Double-Digit UpsideMarch 10, 2024 12:48 PM ETLyft Resets the Stage For Its Path to Profitability Reviewed by Chris MarkochNASDAQ:LYFTNYSE:UBERNASDAQ:AMZNRead Lyft Resets the Stage For Its Path to Profitability March 7, 2024 4:23 AM ETOkta Raises EPS Forecasts Despite High Profile Security BreachesReviewed by Chris MarkochNASDAQ:OKTANASDAQ:GOOGLNASDAQ:GOOGRead Okta Raises EPS Forecasts Despite High Profile Security BreachesMarch 7, 2024 4:10 AM ETSamsara Stock Nears Major Breakout Ahead of Upcoming EarningsReviewed by Chris MarkochNYSE:IOTRead Samsara Stock Nears Major Breakout Ahead of Upcoming EarningsMarch 7, 2024 4:05 AM ETPaymentus Is a Tech Stock You’re Going To Hear a Lot More AboutReviewed by Chris MarkochNYSE:PAYRead Paymentus Is a Tech Stock You’re Going To Hear a Lot More AboutMarch 6, 2024 10:33 AM ETPalantir Stock Spikes 6% on U.S. Army TITAN ContractChris MarkochNYSE:PLTRRead Palantir Stock Spikes 6% on U.S. Army TITAN ContractMarch 6, 2024 5:15 AM ETBUD Stock Reverses on Lower Bud Light Sales, Is the Bottom In?Chris MarkochNYSE:BUDRead BUD Stock Reverses on Lower Bud Light Sales, Is the Bottom In?March 6, 2024 4:30 AM ETHere’s the One Chinese EV Stock Worth Buying and HoldingReviewed by Chris MarkochNASDAQ:LITSE:LINYSE:NIORead Here’s the One Chinese EV Stock Worth Buying and HoldingMarch 6, 2024 4:19 AM ETBeam Therapeutics Bolts Higher on Gene Therapy Licensing PaymentsReviewed by Chris MarkochNASDAQ:BEAMNYSE:LLYNASDAQ:CRSPRead Beam Therapeutics Bolts Higher on Gene Therapy Licensing PaymentsMarch 6, 2024 4:13 AM ETVivani Medical Surges on its Ozempic-Like Weight-Loss ImplantReviewed by Chris MarkochNASDAQ:VANINYSE:NVONYSE:LLYRead Vivani Medical Surges on its Ozempic-Like Weight-Loss ImplantMarch 6, 2024 4:07 AM ETAbercrombie & Fitch Stock Just Got an Upgrade to Beat Its PeersReviewed by Chris MarkochNYSEARCA:XLYNYSE:CNYSE:UBSRead Abercrombie & Fitch Stock Just Got an Upgrade to Beat Its PeersMarch 5, 2024 5:08 AM ETIs UnitedHealth Group Stock a Strong Buy or a Falling Knife?Chris MarkochNYSE:UNHNASDAQ:PANWNYSE:HUMRead Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?March 5, 2024 5:00 AM ETCathie Wood Likes UiPath Stock Over NVDA, Should You?Chris MarkochNYSE:PATHNASDAQ:NVDANYSEARCA:ARKKRead Cathie Wood Likes UiPath Stock Over NVDA, Should You?March 5, 2024 4:15 AM ETFoot Locker Stock Is the Retail Value Play Growing at 46%Reviewed by Chris MarkochNYSEARCA:XLYNYSE:DKSNYSE:FLRead Foot Locker Stock Is the Retail Value Play Growing at 46% Page 36 of 68 « Most Recent‹ More Recent33343536373839 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
